Literature DB >> 23924030

Factor structure of the Depression Anxiety Stress Scales in individuals with traumatic brain injury.

Dana Wong1, Jane Dahm, Jennie Ponsford.   

Abstract

PRIMARY
OBJECTIVE: The Depression Anxiety Stress Scales (DASS) and its shorter version, the DASS21, demonstrate a consistent factor structure. However, when these scales are used with people with traumatic brain injury (TBI), it is possible that TBI symptoms that overlap with anxiety and depression (e.g., irritability, inertia, emotional lability) result in changes to the underlying structure. This study aimed to establish whether the factor structure of the DASS and DASS21 when used with individuals with TBI is consistent with the three scales designated in the manual. METHODS AND PROCEDURES: One hundred and twenty-three participants with mild-to-severe TBI completed the DASS. MAIN OUTCOMES AND
RESULTS: The factor structure of the DASS was found to be consistent with the designated scales, with the exception of four items that cross-loaded weakly on multiple factors. However, the factor structure of the DASS21 did not correspond as closely to the designated depression, anxiety and stress scales, which appeared to be due to the fact that many of the highest loading items on the DASS were not included items in the DASS21.
CONCLUSIONS: These results indicate that it may be preferable to use the full DASS, rather than the DASS21, with individuals with TBI.

Entities:  

Mesh:

Year:  2013        PMID: 23924030     DOI: 10.3109/02699052.2013.823662

Source DB:  PubMed          Journal:  Brain Inj        ISSN: 0269-9052            Impact factor:   2.311


  5 in total

Review 1.  Stem cells and G-CSF for treating neuroinflammation in traumatic brain injury: aging as a comorbidity factor.

Authors:  I Dela Peña; P R Sanberg; S Acosta; N Tajiri; S Z Lin; C V Borlongan
Journal:  J Neurosurg Sci       Date:  2014-05-20       Impact factor: 2.279

2.  The influence of self-reported history of mild traumatic brain injury on cognitive performance.

Authors:  Amaya J Fox; Hannah L Filmer; Paul E Dux
Journal:  Sci Rep       Date:  2022-10-11       Impact factor: 4.996

3.  Combination therapy of human umbilical cord blood cells and granulocyte colony stimulating factor reduces histopathological and motor impairments in an experimental model of chronic traumatic brain injury.

Authors:  Sandra A Acosta; Naoki Tajiri; Kazutaka Shinozuka; Hiroto Ishikawa; Paul R Sanberg; Juan Sanchez-Ramos; Shijie Song; Yuji Kaneko; Cesar V Borlongan
Journal:  PLoS One       Date:  2014-03-12       Impact factor: 3.240

Review 4.  Cell therapy for central nervous system disorders: Current obstacles to progress.

Authors:  Takao Yasuhara; Satoshi Kawauchi; Kyohei Kin; Jun Morimoto; Masahiro Kameda; Tatsuya Sasaki; Brooke Bonsack; Chase Kingsbury; Naoki Tajiri; Cesario V Borlongan; Isao Date
Journal:  CNS Neurosci Ther       Date:  2019-10-17       Impact factor: 5.243

Review 5.  Granulocyte-colony stimulating factor and umbilical cord blood cell transplantation: Synergistic therapies for the treatment of traumatic brain injury.

Authors:  Michael G Liska; Ike Dela Peña
Journal:  Brain Circ       Date:  2017-10-12
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.